Linda Barton v. HHS - Influenza, Guillain Barre Syndrome (GBS) (2017)
Case summary [AI summaries can sometimes make mistakes]
Michael Barton, as administrator of the estate of Linda Barton, deceased, filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program. The petition sought compensation for injuries allegedly related to Ms.
Barton's receipt of the influenza vaccine on or about October 3, 2013. Ms.
Barton was diagnosed with Guillain-Barre Syndrome (GBS), and the petitioner alleged that she experienced residual effects of this injury for more than six months. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused Ms.
Barton's alleged GBS or any other injury or her death. The parties reached a stipulation to settle the case, agreeing that a decision should be entered awarding compensation.
Special Master George L. Hastings reviewed the file and concluded that the stipulation was appropriate.
The decision ordered that the petitioner shall receive a lump sum of $255,000.00, payable to the petitioner as the legal representative of the estate of Linda Barton, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The petition was filed on April 26, 2016, and the decision was issued on May 31, 2017.
The stipulation stated that it was a full and complete negotiated settlement of liability and damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, and that it was not an admission by the United States or the Secretary that the flu vaccine caused Ms. Barton's alleged GBS, any other injury, or her death.
The petitioner also agreed to submit to further proceedings for the award of reasonable attorneys' fees and costs.
Theory of causation
Petitioner alleged that the influenza vaccine administered on or about October 3, 2013, caused Linda Barton to develop Guillain-Barre Syndrome (GBS) with residual effects lasting more than six months. The respondent denied causation. The case was settled by stipulation, resulting in an award of $255,000.00. The public decision does not describe the specific medical experts, clinical details of the GBS onset or progression, diagnostic tests, treatments, or the mechanism of causation. The case was brought under the National Vaccine Injury Compensation Program, and GBS is listed on the Vaccine Injury Table for the influenza vaccine, suggesting a potential "Table" claim theory, though the stipulation does not explicitly state this was the basis for settlement. The decision was issued by Special Master George L. Hastings on May 31, 2017, based on a stipulation filed on May 2, 2017, with the petition filed on April 26, 2016. Attorneys for the petitioner and respondent are not named in the provided text.
Source PDFs
USCOURTS-cofc-1_16-vv-00508